First, do no harm? Common anticholinergic meds seen to increase dementia risk in older patients

Com­mon­ly Pre­scribed Meds Could Raise Demen­tia Risk (Web­MD): “Doc­tors often pre­scribe anti­cholin­er­gic drugs for a vari­ety of ills. But a new study sug­gests they may increase the risk of demen­tia in old­er patients. These med­i­cines include every­thing from Benadryl (diphen­hy­dramine) to cer­tain antipsy­chotics and Parkin­son’s meds. They’re used to treat a wide range of other…

Read More

Does marijuana use cause schizophrenia? (unclear, but unlikely)

Does Mar­i­jua­na Use Cause Schiz­o­phre­nia? (The New York Times): “… The con­cern is focused large­ly on the link between heavy usage and psy­chosis in young peo­ple. Doc­tors first sus­pect­ed a link some 70 years ago, and the evi­dence has only accu­mu­lat­ed since then. In a forth­com­ing book, “Tell Your Chil­dren,” Alex Beren­son, a for­mer Times reporter,…

Read More

Study: Common medication treatments for PTSD can increase the risk of developing dementia

—– Drugs for PTSD linked to increased risk of demen­tia (The Phar­ma­ceu­ti­cal Jour­nal): “Cer­tain psy­chotrop­ic drugs used to treat post-trau­­mat­ic stress dis­or­der (PTSD) increase the risk of devel­op­ing demen­tia, includ­ing in patients who do not have PTSD but take the drugs for oth­er con­di­tions, study results pub­lished in the Jour­nal of the Amer­i­can Geri­atrics Society

Read More

Therapy or antidepressants? Coming soon: Brain activity “fingerprints” to personalize depression treatments

. To Treat Depres­sion, Drugs or Ther­a­py? (The New York Times): “Until recent­ly, many experts thought that your clin­i­cian could lit­er­al­ly pick any anti­de­pres­sant or type of psy­chother­a­py at ran­dom because, with a few clin­i­cal excep­tions, there was lit­tle evi­dence to favor one treat­ment over anoth­er for a giv­en patient

Read More

Upcoming Webinar: The Digital Brain Health & Training Market in 2014

When: Thurs­day, March 13, 2014 from 12:30 PM to 2:00 PM (EDT) Join this upcom­ing webi­nar, to be held dur­ing Brain Aware­ness Week 2014, to dis­cuss the lat­est mar­ket data and news in the dig­i­tal brain health and brain train­ing space, includ­ing Roset­ta Stone’s acqui­si­tion of Viv­i­ty Labs (devel­op­er of Fit Brains mobile cog­ni­tive games), Bay­er’s glob­al partnership…

Read More